Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Camez

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|October 10, 1998
[Refludan. First line of treatment for type II heparin-induced thrombopenia]A Camez
La Revue Du Praticien|November 1, 1992
[The promises of new antithrombotic agents]A Camez, D Levy
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Angiogenic factors]A Camez, G Tobelem
Blood Reviews|March 1, 1987
The lupus anticoagulant and its role in thrombosisG Tobelem, R Cariou, A Camez
Invasion & Metastasis|January 1, 1986
Human platelet-tumor cell interactions vary with the tumor cell linesA Camez, E Dupuy, S Bellucci, et al.
Thrombosis Research|December 15, 1991
Locally activated coagulation induced by a peripheral endovenous catheterP Sié, A Camez, E Derobert, et al.
Thrombosis and Haemostasis|April 1, 1997
Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patientsR Vanholder, A Camez, N Veys, et al.
Presse Medicale (Paris, France : 1983)|March 15, 1986
[Course of the manifestations associated with the antiprothrombinase circulating anticoagulant]A Camez, G Tobelem, S Bellucci, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1995
[Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study]F Schiele, A Vuillemenot, T Mouhat, et al.
Kidney International|June 1, 1994
Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysisR C Vanholder, A A Camez, N M Veys, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|October 10, 1998
[Refludan. First line of treatment for type II heparin-induced thrombopenia]A Camez
La Revue Du Praticien|November 1, 1992
[The promises of new antithrombotic agents]A Camez, D Levy
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Angiogenic factors]A Camez, G Tobelem
Blood Reviews|March 1, 1987
The lupus anticoagulant and its role in thrombosisG Tobelem, R Cariou, A Camez
Invasion & Metastasis|January 1, 1986
Human platelet-tumor cell interactions vary with the tumor cell linesA Camez, E Dupuy, S Bellucci, et al.
Thrombosis Research|December 15, 1991
Locally activated coagulation induced by a peripheral endovenous catheterP Sié, A Camez, E Derobert, et al.
Thrombosis and Haemostasis|April 1, 1997
Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patientsR Vanholder, A Camez, N Veys, et al.
Presse Medicale (Paris, France : 1983)|March 15, 1986
[Course of the manifestations associated with the antiprothrombinase circulating anticoagulant]A Camez, G Tobelem, S Bellucci, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1995
[Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study]F Schiele, A Vuillemenot, T Mouhat, et al.
Kidney International|June 1, 1994
Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysisR C Vanholder, A A Camez, N M Veys, et al.
Pageof 2